Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001709738-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | NMTC | Christianson Mark | Business Development Dir | S - Sale | $0.74 | -30.0K | 231.2K | -11% | -$22.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 30,000 | $0.74 | 231,238 | D | — | — | (F1) The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.7400 to $0.7518 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |